Responses were similar among patients with estrogen patches and ARPIs compared to luteinizing hormone releasing hormone ...

Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange for milestone payments Nutriband is partnering with ...

Aversa Fentanyl holds the potential to become the world’s first abuse-deterrent opioid patch.

Alvogen has issued a nationwide recall of one lot of Fentanyl Transdermal System 25 patches because the patches may stick ...

The U.S. Food and Drug Administration announced last week that a pharmaceutical company is removing a fentanyl patch from ...

These patches are more formally referred to as ‘transdermal patches’ or ‘skin patches’ as they use a Transdermal Drug Delivery System (TDDS). TDDS, in simple words, is a system that ...

A mid-stage study reveals that transdermal estradiol patches may match traditional androgen deprivation therapy in treating prostate cancer with fewer side effects. This approach boosts bone density ...

When it comes to the safe use of synthetic opioids like fentanyl, precise dosing of the powerful pain meds is key. Now, ...

Alvogen Inc. is recalling 1 lot of Fentanyl Transdermal System 25mcg/h transdermal patches due to the potential for multi-stacked patches (adhered one on top of the other) in a single product pouch.

With 90% of the U.S. population living within 10 miles of a Walmart store, recalls of products they sell can have widespread ...

The AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 countries including the United States, Europe ...